Current prevention efforts for Type 2 diabetes (T2D) have largely targeted individuals after dysglycemia is established. The authors propose a conceptual shift: reframing prevention around prediabetes remission, with preservation and restoration of normoglycemia defined as the optimal clinical goal. This reframing emphasizes reversing intermediate hyperglycemia rather than delaying progression after substantial metabolic disturbance has already occurred.
The article presents a life-course risk architecture for T2D that integrates developmental, transitional and contextual determinants. T2D risk is described as cumulatively shaped by biological, behavioral and environmental exposures occurring throughout life. This architecture highlights that risk accrues progressively as individuals transition from normoglycemia through increasing dysglycemia to overt disease.
Within the life-course framework, the authors identify periods that represent critical windows of amplified metabolic vulnerability. These windows are times when exposures or interventions may have disproportionately large effects on future glycemic trajectory and on the ability to preserve or restore normoglycemia. The perspective emphasizes recognizing these windows to prioritize timely interventions, although specific windows and their quantitative impact are not detailed in the previewed text.
The authors argue that prediabetes remission (remission of intermediate hyperglycemia) is an achievable, pragmatic and measurable target for prevention programs. Framing remission as the primary aim reframes success away from simply delaying diagnosis of T2D toward actively restoring metabolic health. The article positions remission as both a clinical outcome and a public health objective that can be operationalized in prevention strategies.
A core recommendation is that prevention should embrace precision prevention by targeting mechanistic heterogeneity in T2D pathogenesis. Because the transition to T2D reflects heterogeneous contributions of insulin resistance, β-cell dysfunction and other mechanisms, effective prevention will require interventions aligned to specific mechanistic profiles. The authors emphasize tailoring interventions by mechanism while maintaining pragmatic considerations for implementation.
Aligned with precision, the article underscores that prevention strategies must remain scalable, affordable and adaptable across socioeconomic settings. This means designing interventions that can be delivered at population scale, that are feasible within constrained resources, and that can be adapted to diverse social and environmental contexts. The preview does not provide operational examples or specific implementation models, but stresses these attributes as necessary for equitable impact.
The authors set out a framework identifying ten priorities for T2D prevention. These priorities aim to move beyond traditional approaches toward context-specific, actionable interventions capable of altering disease natural history early in the life course and restoring metabolic health. The previewed material states the existence of these ten priorities but does not enumerate them or supply their detailed content; full details were not reported in the accessible abstract and preview.
The article includes a figure illustrating long-term cardiometabolic benefits associated with prediabetes remission, indicating that restoring normoglycemia may confer sustained advantages for cardiometabolic health. A second figure depicts life-course accumulated diabetes risk. Specific quantitative outcomes, effect sizes or longitudinal data underpinning these figures are not available in the previewed content; readers are referred to the full article for complete results and evidence supporting the schematic illustrations.
Notes on evidence and access
This perspective synthesizes conceptual arguments and places them within a broader context of diabetes prevalence, economic burden and guideline documents referenced in the article. The preview includes citations to recent global prevalence and burden reports and to professional guidance (for example, diabetes atlas estimates and practice guidelines), but the full text, detailed evidence synthesis, and the explicit ten priorities are behind subscription access and were not fully reported in the available preview.
Key terminology highlighted
Concluding summary
The perspective calls for reframing T2D prevention across the life course to prioritize remission of prediabetes and restoration of normoglycemia. It presents a life-course risk architecture, highlights windows of increased vulnerability, and argues for precision, scalable and context-sensitive interventions. The framework culminates in ten priorities intended to guide actionable prevention strategies; full details are available in the complete article.